KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback